These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15531733)

  • 1. Alternatives to nitric oxide.
    Lowson SM
    Br Med Bull; 2004; 70():119-31. PubMed ID: 15531733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled nitric oxide combined with prostacyclin and adrenomedullin in acute respiratory failure with pulmonary hypertension in piglets.
    Dani C; Pavoni V; Corsini I; Longini M; Gori G; Giannesello L; Perna A; Gritti G; Paternostro F; Forestieri A; Buonocore G; Rubaltelli FF
    Pediatr Pulmonol; 2007 Nov; 42(11):1048-56. PubMed ID: 17902148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term inhaled nitric oxide plus phosphodiesterase 5 inhibitors for severe pulmonary hypertension.
    Pérez-Peñate GM; Juliá-Serdà G; Ojeda-Betancort N; García-Quintana A; Pulido-Duque J; Rodríguez-Pérez A; Cabrera-Navarro P; Gómez-Sánchez MA
    J Heart Lung Transplant; 2008 Dec; 27(12):1326-32. PubMed ID: 19059113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pulmonary hypertension with selective pulmonary vasodilators.
    Haj RM; Cinco JE; Mazer CD
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):88-95. PubMed ID: 16547439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
    Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
    Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term inhaled nitric oxide plus dipyridamole for pulmonary arterial hypertension.
    Pérez-Peñate G; Cabrera Navarro P; Ponce González M; Górriz Gómez E; Pulido Duque J; García Quintana A; Juliá Serdá G
    Respiration; 2005; 72(4):419-22. PubMed ID: 16088287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension, pulmonary blood vessels and vasoactive drugs.
    Wanstall JC
    Proc West Pharmacol Soc; 1997; 40():137-40. PubMed ID: 9436235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
    Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
    Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of inhaled nitric oxide in newborn medicine.
    Golombek SG
    Heart Dis; 2000; 2(5):342-7. PubMed ID: 11728280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension, nitric oxide and nitric oxide-releasing compounds.
    Hagan G; Pepke-Zaba J
    Expert Rev Respir Med; 2011 Apr; 5(2):163-71. PubMed ID: 21510727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular pathophysiology and therapy of pulmonary hypertension.
    Olschewski H; Rose F; Grünig E; Ghofrani HA; Walmrath D; Schulz R; Schermuly R; Grimminger F; Seeger W
    J Lab Clin Med; 2001 Dec; 138(6):367-77. PubMed ID: 11753283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of inhaled nitric oxide for emergency Cesarean section in a woman with unexpected primary pulmonary hypertension.
    Decoene C; Bourzoufi K; Moreau D; Narducci F; Crepin F; Krivosic-Horber R
    Can J Anaesth; 2001 Jun; 48(6):584-7. PubMed ID: 11444454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.
    Yin N; Kaestle S; Yin J; Hentschel T; Pries AR; Kuppe H; Kuebler WM
    Crit Care Med; 2009 Mar; 37(3):980-6. PubMed ID: 19237907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled iloprost in pulmonary arterial hypertension.
    Baker SE; Hockman RH
    Ann Pharmacother; 2005; 39(7-8):1265-74. PubMed ID: 15976392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy.
    Kramm T; Eberle B; Guth S; Mayer E
    Eur J Cardiothorac Surg; 2005 Dec; 28(6):882-8. PubMed ID: 16242948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating the pulmonary circulation: an update.
    Dembinski R; Henzler D; Rossaint R
    Minerva Anestesiol; 2004 Apr; 70(4):239-43. PubMed ID: 15173703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
    Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology and efficacy of inhaled iloprost for the treatment of pulmonary arterial hypertension.
    John J; Palevsky H
    Expert Rev Clin Pharmacol; 2011 Mar; 4(2):197-205. PubMed ID: 22115402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhaled vasodilators].
    Zwissler B
    Anaesthesist; 2002 Aug; 51(8):603-24. PubMed ID: 12391520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
    Lee JE; Hillier SC; Knoderer CA
    J Intensive Care Med; 2008; 23(5):329-34. PubMed ID: 18701525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.